Anne Bailey has been appointed vice president of diagnostics and reagents at NaPro Biotherapeutics, and general manager of the company’s genomics division, the Boulder, Colo., company said Dec. 22. Bailey indirectly replaces Jeffrey White, who is stepping down Jan. 2 from his post as president of the company’s genomics division “to pursue other opportunities.” Bailey was most recently vice president of diagnostics at Variagenics, which merged with Hyseq in February to become Nuvelo.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.